9/11 Pulmonary Fibrosis: Interstitial Lung Disease Claims & VCF Compensation

Who qualifies for 9/11 pulmonary fibrosis compensation?

Anyone diagnosed with pulmonary fibrosis following presence in the covered 9/11 areas, at the Pentagon, or in Shanksville, Pennsylvania during the covered periods may qualify for VCF compensation. This includes area workers, residents, students, teachers, first responders, cleanup and recovery workers, volunteers, and surviving family members of those who died from 9/11-related pulmonary fibrosis.

Free medical care runs through the WTC Health Program, which covers Manhattan south of Houston Street and any block in Brooklyn within 1.5 miles of the former World Trade Center site. Compensation runs through the VCF, which covers Manhattan south of Canal Street plus routes of debris removal.

If you were between Canal and Houston Street, you may still qualify for both. Daily life in Lower Manhattan rarely stopped at Canal Street, and presence can be established with records or sworn affidavits.

How is pulmonary fibrosis certified under the WTC Health Program?

Pulmonary fibrosis is certified within the interstitial lung disease (ILD) category, the WTC Health Program's category for restrictive and scarring lung conditions. Unlike sarcoidosis and asbestosis, pulmonary fibrosis is not named as its own separate condition on the WTC Health Program's list; it is certified as one of the recognized types of interstitial lung disease, which the Program treats as a single category rather than a fixed list of named diseases.

Pulmonary fibrosis is scarring of the lung tissue that stiffens the lungs and makes it progressively harder to breathe. Inhaled dust and fine particles released by the collapse of the World Trade Center were able to reach deep into the lung parenchyma, the same tissue that fibrotic disease affects, and toxicology studies of WTC dust identified the causative agents.

Among NYC WTC responders and survivors, interstitial lung disease, including pulmonary fibrosis, has been documented alongside sarcoid-like granulomatous pulmonary disease, with numerous cases first diagnosed in the years following the attacks. Because interstitial lung disease can progress with a silent period before symptoms appear, published research on the WTC-exposed population has recognized that its true incidence may still be underestimated.

Certification does not require proof that 9/11 exposure was the only cause of the condition. The legal standard is whether the exposure was substantially likely to be a significant factor in aggravating, contributing to, or causing it.

Pulmonary fibrosis typically develops gradually. Common symptoms include shortness of breath that worsens over time, a persistent dry cough, fatigue, unexplained weight loss, and aching muscles and joints. As the disease progresses, some people develop widening and rounding of the fingertips and toes, known as clubbing.

Because these symptoms overlap with many other lung conditions, pulmonary fibrosis is typically confirmed through imaging, such as a high-resolution CT scan, and pulmonary function testing showing a restrictive pattern. A lung biopsy is sometimes needed to confirm the diagnosis and rule out other causes.

Anyone with 9/11 exposure history who develops these symptoms should be evaluated by a WTC Health Program participating provider. The diagnosis can be made by any qualified physician, but certification of the condition as 9/11-related is made by the WTC Health Program.

Pulmonary fibrosis falls within interstitial lung disease, the one WTC Health Program aerodigestive category with no maximum time interval. The Administrator reviewed the published science on interstitial disease and determined that it can have an insidious, silent onset, and that no reliable evidence supported selecting a cutoff. The same policy also does not require a minimum time interval for any aerodigestive category.

This means a pulmonary fibrosis diagnosis can be certified as 9/11-related regardless of how long ago the qualifying exposure occurred, and regardless of how soon after exposure symptoms first appeared. This latency framework was set by the WTC Health Program Administrator in the Time Intervals for New-Onset Aerodigestive Disorders policy, most recently revised August 30, 2017, and has no exceptions.

The two-year VCF registration deadline runs from the date the WTC Health Program certifies the pulmonary fibrosis as 9/11-related, not from the date of diagnosis. A pulmonary fibrosis diagnosis from years ago remains eligible for certification and compensation review if registration is completed within the applicable window.

How much does the VCF pay for 9/11 pulmonary fibrosis?

Certified 9/11 pulmonary fibrosis qualifies claimants for free medical treatment through the WTC Health Program and allows the claimant to submit a claim for financial compensation through the September 11th Victim Compensation Fund. The VCF's non-economic loss award for pulmonary fibrosis is published in its Non-Economic Loss Awards and Certified Conditions Fact Sheet.

Presumptively severe award

• Pulmonary fibrosis baseline: $90,000. The VCF has determined that interstitial lung disease, the category pulmonary fibrosis falls under, is presumptively severe and debilitating, warranting the statutory ceiling for a single non-cancer condition.
• No additional documentation required. Unlike most non-cancer conditions, which start lower in the $10,000 to $90,000 range and rise with medical evidence of severity, a certified pulmonary fibrosis diagnosis is awarded the $90,000 ceiling without submitting further records beyond the certification itself.
• Severe cases. Pulmonary fibrosis requiring a lung transplant or significant daily mechanical respiratory assistance is treated as an especially severe presentation within the same $90,000 non-cancer ceiling.

Economic loss and wrongful death

In addition to non-economic loss, the VCF may award economic loss for medical expenses and lost earnings. Wrongful death compensation is available to the personal representatives of individuals who died from 9/11-related pulmonary fibrosis. Attorney fees for VCF claims are capped at 10% by federal statute.

Additional certified conditions do not automatically raise a VCF award. Non-economic loss for non-cancer conditions is capped at $90,000 for a single condition, and the VCF's aggregate maximum of $340,000 is reserved for claims involving two or more certified cancers or a certified cancer alongside another certified condition of extraordinary severity. A certified cancer is required to reach that higher figure.

How Baione Law handles a 9/11 pulmonary fibrosis claim

Baione Law represents 9/11 pulmonary fibrosis claimants at every stage:

1. Free Case Review. The firm evaluates presence in the exposure zone, exposure category, pulmonary fibrosis diagnosis, and current WTC Health Program certification status. No cost, no obligation.
2. WTC Health Program enrollment and certification support. For claimants not yet enrolled, the firm assists with enrollment and coordinates medical record submission to WTC Health Program providers for certification.
3. VCF registration and claim filing. The firm registers the claim, files the compensation claim, and prepares supporting documentation including presence, exposure, diagnosis, and treatment history.
4. Medical records and impact documentation. The firm compiles the medical, economic, and non-economic loss documentation the VCF requires.
5. Award, appeals, and amendments. After the VCF issues an award, the firm reviews it, files an appeal if warranted, and handles amendments for subsequent certified conditions or documented progression of the pulmonary fibrosis.

Attorney fees are capped at 10% by federal statute.